1 Min Read
NEW YORK, Jan 9 (Reuters) - Intercept Pharmaceuticals Inc : * Pharma surges 133.3 percent to $168.87 in premarket trade after liver disease drug meets main goal in study
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.